article · PubMed
Pathogenic <i>Escherichia coli</i> is one of the world's most important zoonotic foodborne pathogens and poses a serious threat to public health. We examined the prevalence, virulence genes, and antibiotic resistance profile of Shiga toxin (Stx)-producing <i>E. coli</i> (STEC) isolated from broiler chickens in the Kafr El-Sheikh governorate, Egypt. A total of 410 samples (230 cloacal swabs, 180 internal organs) were collected to isolate <i>E. coli</i>. A total of 29 (7.07%) <i>E. coli</i> isolates were recovered and identified, and 18 of them harbored <i>Stx</i> genes (<i>stx</i>). Out of 18 isolates, five (17.24%) carried the <i>stx</i> <i>1</i> gene, five (17.24%) carried the <i>stx</i> <i>2</i> gene, four (13.79%) carried both <i>stx</i> <i>1</i> and <i>stx</i> <i>2</i> genes, and four (13.79%) carried <i>stx</i> <i>1</i> <i>, stx</i> <i>2</i> <i>,</i> and <i>eae</i> <i>A</i> genes. Overall, complete anti-biotic resistance was observed against amoxicillin, ampicillin, cefpodoxime, and cefoperazone; high resistance was observed against ampicillin/sulbactam, nalidixic acid, cefuroxime, aztreonam, ciprofloxacin, ceftriaxone, chloramphenicol, sulfamethoxazole/trimethoprim, and ceftazidime; moderate resistance against gentamicin; low resistance against cefoxitin; lower resistance was detected against norfloxacin, cefotetan, and amikacin; and the lowest resistance against imipenem. All <i>E. coli</i> isolates demonstrated multidrug resistance against at least four antibiotic classes. Out of 29 <i>E. coli</i> isolates, STEC accounted for 18 isolates, of which the O78, O26:H11, O128:H2, O1:H7, O119:H6, and O91:H21 serogroups were predominant. All <i>E. coli</i> isolates were multidrug resistant and therefore pose a potential public health concern as these virulent, resistant strains may spread to humans. Thus, high levels of hygiene and biosecurity are required by chicken handlers to decrease the danger of infection spreading to humans.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.30466/vrf.2021.539418.3233
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.